Cannabidiol products are widely sold as supplements, but in the EU an extract of this kind has been treated as a novel food that requires authorisation, and no authorisation has been granted. The scientific assessment has stalled for lack of safety data, leaving operators in a legal grey zone that carries real enforcement risk.
Where the assessment stands
In June 2022, EFSA announced that evaluations of cannabidiol as a novel food were on hold pending new data. It had received 19 applications, and stated that many data gaps needed filling, including effects on the liver, the gastrointestinal tract, the endocrine and nervous systems, psychological well-being and reproductive toxicity, where animal studies showed significant adverse effects. EFSA stressed that it had not concluded CBD is unsafe, only that it could not establish safety on the data available. Check the Commission Novel Food Catalogue and EFSA for any later development before relying on this position.
What it means for a supplement business
- A CBD extract is not a recognised ingredient in an authorised supplement unless it is authorised as a novel food.
- National enforcement approaches have varied, and a product tolerated in one country can be withdrawn in another.
- Medicinal claims would add the separate risk of medicinal product classification.
Hemp-derived ingredients more generally
Not every hemp ingredient is novel. Whether a given hemp seed, oil or extract has a history of consumption before 15 May 1997 depends on the exact part and preparation, and must be evidenced. Isolated or concentrated cannabinoids are the high-risk category.
A sensible approach
Do not launch on the assumption that the issue will resolve. Document the exact ingredient and its history of use, seek a view from the national authority where there is real doubt, and keep contracts with suppliers clear about who bears the regulatory risk.
How PQRA helps
PQRA assesses novel food status for cannabinoid and hemp-derived ingredients and advises on the regulatory risk of launching in Greece, Cyprus and the EU.


No responses yet